Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study (Q36088599)

12 August 2017

Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study (English)

1 reference

12 August 2017

0 references

M Wallace

1

1 reference

12 August 2017

R L Rauck

2

1 reference

12 August 2017

D Moulin

3

1 reference

12 August 2017

J Thipphawong

4

1 reference

12 August 2017

S Khanna

5

1 reference

12 August 2017

I C Tudor

6

1 reference

12 August 2017

1 October 2007

1 reference

International Journal of Clinical Practice

12 August 2017

1 reference

12 August 2017

61

1 reference

12 August 2017

10

1 reference

12 August 2017

1671-1676

1 reference

Opioids in chronic non-cancer pain, indications and controversies

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040191

Hydromorphone for acute and chronic pain.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040191

Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040191

Hydromorphone: pharmacology and clinical applications in cancer patients.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040191

Managing chronic nonmalignant pain: overcoming obstacles to the use of opioids

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040191

Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040191

Pharmacokinetics and Bioavailability of Hydromorphone Following Intravenous and Oral Administration to Human Subjects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040191

Effects of controlled-released morphine on quality of life for cancer pain

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040191

More on the conversion of transdermal fentanyl to morphine.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040191

Subcutaneous infusions for control of cancer symptoms

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040191

Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040191

Pain reduced and quality of life improved by sustained-release hydromorphone. Results of an observational study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040191

Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040191

Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040191

Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040191

Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17877652

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17877652

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17877652

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1742-1241.2007.01500.X

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

17877652

1 reference